Gene-Disorder Association · Article
Gene
ADRB2 Adrenoceptor Beta 2
×
First reported
2007
Supporting publications
25
Manually curated Approved treatment annotated
Association Review
In brief The association between ADRB2 (Adrenoceptor Beta 2) and Body Mass Index Quantitative Trait Locus 11 is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
6
Compounds
1
Trials
0 of 78 via ADRB2 compounds
Publications
25
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access 02
Provenance
Evidence and sources 1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access 2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access 04
Body Mass Index Quantitative Trait Locus 11
The disorder 13 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access 05
Phenotype
Clinical features 3 clinical features
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access 06
Interventions
Therapeutics 1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access 07
Human studies
Clinical trials 78 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access 25 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access 09
Provenance
References & sources 14 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access 
